Saturday 17 October 2026
Export MPLT’s income statement to Excel — free account
MapLight Therapeutics, Inc.
MPLT Healthcare Biotechnology
In the quarter to June 2026, EPS grew 96.6% and free cash flow fell 31.9%, each against the same quarter a year earlier. Insiders bought in the last twelve months.
7.70
0.32
−3.99%
Follow MPLT
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+4 more TTM periods Free account |
0.00% | 0.00% | 0.00% | (297.18%) | |
| (78.24%) | (67.22%) | (95.27%) | (124.79%) | ||
ROIC |
(1,049.52%) | (68.95%) | (146.32%) | (348.44%) | |
Return on Tangible Assets |
(44.21%) | (52.06%) | (63.55%) | (76.53%) | |
Free Cash Flow per Share |
(143.68) | (15.98) | (3.63) | (3.85) | |
Free Cash Flow |
(113.66) | (138.72) | (164.26) | (175.12) | |
Capital Expenditures |
(0.87) | (0.58) | (0.50) | (0.45) | |
| Other line items | |||||
Cash ROIC |
(24.67%) | (18.17%) | (23.14%) | (26.82%) | |
Accounts Payable Turnover |
— | — | — | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Operating CF/Net income |
1.12 | 0.86 | 0.82 | 0.76 | |
Depreciation/Fixed assets |
(0.51) | (1.39) | (2.15) | (3.78) | |
Capex/Depreciation |
1.98 | 0.38 | 0.24 | 0.14 | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(142.58) | (15.91) | (3.62) | (3.84) | |
Capex per Share |
(1.10) | (0.07) | (0.01) | (0.01) | |
Capex to Sales |
0.00 | 0.00 | 0.00 | 0.00 |
Columns are period end dates